Insider · CIK 0001190578

MARTIN JOHN C

Reports to the SEC for 4 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001190578

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-03	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,726 sh	—	—	7,913
2021-03-03	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,518 sh	—	—	5,518
2020-10-14	Kronos Bio, Inc.C Conversion	Director	CConversion	+914K sh	—	—	914,333
2020-10-14	Kronos Bio, Inc.C Conversion	Director	CConversion	+757K sh	—	—	1,671,304
2020-10-14	Kronos Bio, Inc.C Conversion	Director	CConversion	+205K sh	$16.15	+$3.31M	1,876,564
2020-10-14	Kronos Bio, Inc.P Purchase	Director	PPurchase	+75.8K sh	$19.00	+$1.44M	1,952,364
2020-10-14	Kronos Bio, Inc.Series Seed Preferred StockC Conversion	Director	CConversion	−867K sh	—	—	0
2020-10-14	Kronos Bio, Inc.Series A Preferred StockC Conversion	Director	CConversion	−718K sh	—	—	0
2020-10-14	Kronos Bio, Inc.Convertible Promissory NoteC Conversion	Director	CConversion	—	—	—	0
2020-02-28	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+3,112 sh	—	—	3,112
2020-02-28	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,075 sh	—	—	5,187
2020-02-28	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+5,528 sh	—	—	5,528
2020-02-28	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+3,685 sh	—	—	3,685
2019-02-06	GILDGILEAD SCIENCES, INC.A Award	Director	AAward	+7,745 sh	—	—	2,885,507
2019-02-06	GILDGILEAD SCIENCES, INC.A Award	Director	AAward	+15.5K sh	—	—	2,901,012
2019-02-06	GILDGILEAD SCIENCES, INC.F Tax Payment	Director	FTax Payment	−13.8K sh	$68.75	−$948K	2,887,225
2018-12-03	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$23.60	+$1.18M	2,927,762
2018-12-03	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−35.8K sh	$70.90	−$2.54M	2,891,920
2018-12-03	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−14K sh	$71.95	−$1M	2,877,962
2018-12-03	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−200 sh	$72.67	−$14.5K	2,877,762
2018-12-03	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	0
2018-11-29	GILDGILEAD SCIENCES, INC.G Gift	Director	GGift	−140K sh	—	—	2,877,762
2018-11-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$23.60	+$1.18M	3,067,762
2018-11-01	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−8,000 sh	$68.61	−$549K	3,059,762
2018-11-01	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−28.4K sh	$69.53	−$1.98M	3,031,341
2018-11-01	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−13.6K sh	$70.15	−$953K	3,017,762
2018-11-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	50,000
2018-10-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$23.60	+$1.18M	3,067,762
2018-10-01	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−33.3K sh	$77.90	−$2.6M	3,034,432
2018-10-01	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−16.7K sh	$78.34	−$1.31M	3,017,762
2018-10-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	100,000
2018-09-04	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$23.60	+$1.18M	3,067,762
2018-09-04	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−47.4K sh	$74.11	−$3.51M	3,020,386
2018-09-04	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,624 sh	$75.00	−$197K	3,017,762
2018-09-04	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	150,000
2018-08-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$23.60	+$1.18M	3,067,762
2018-08-01	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−50K sh	$77.85	−$3.89M	3,017,762
2018-08-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	200,000
2018-07-02	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$23.60	+$1.18M	3,067,762
2018-07-02	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−49.7K sh	$70.80	−$3.52M	3,018,062
2018-07-02	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−300 sh	$71.36	−$21.4K	3,017,762
2018-07-02	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	250,000
2018-06-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$23.60	+$1.18M	3,067,762
2018-06-01	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−50K sh	$68.13	−$3.41M	3,017,762
2018-06-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	300,000
2018-05-09	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)A Award	Director	AAward	+9,496 sh	—	—	9,496
2018-05-09	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitA Award	Director	AAward	+2,283 sh	—	—	2,593
2018-05-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$23.60	+$1.18M	3,067,762
2018-05-01	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−50K sh	$72.19	−$3.61M	3,017,762
2018-05-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	350,000

Recent filings

Accepted (ET)
Mar 54
MARTIN JOHN C0001209191-21-018418
SEC(opens sec.gov)
Oct 164
MARTIN JOHN C0001209191-20-055042
SEC(opens sec.gov)
Feb 284
MARTIN JOHN C0001209191-20-014229
SEC(opens sec.gov)
Feb 84
MARTIN JOHN C0001127602-19-004859
SEC(opens sec.gov)
Dec 44
MARTIN JOHN C0001127602-18-035244
SEC(opens sec.gov)

Companies

Address

GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE

FOSTER CITY, CA, 94404